A new biomechanics study from Mass General Brigham, published this week and the latest in a string of papers cautioning elite runners about advanced footwear technology, finds that the highly cushioned, carbon-plated shoes responsible for most of the last decade's marathon time drops also produce loading patterns consistent with a raised risk of bone-stress injury. The team, led by researchers in the Spaulding Rehabilitation Hospital's running clinic, ran twenty-three elite distance runners through a controlled treadmill protocol in three shoe categories: a neutral trainer, a lightweight responsive-foam racing flat, and a current-generation carbon-plated super shoe. The super-shoe trials produced clear differences in how runners absorbed and transmitted force through the lower leg.

The headline finding is that the super shoe shifted vertical loading later into the stance phase, raising the peak loading rate at the medial tibia and reducing how evenly the impact was spread across each foot strike. Those are the same loading-rate signatures that biomechanics literature has linked to tibial stress reactions for more than a decade; the difference now is that the study's subjects were not recreational runners but national- and international-level athletes whose training volumes and race speeds already place their tibias close to a physiological ceiling. The authors note that the shift was not uniform: some athletes, especially those who tended to a mid-foot strike, were largely unaffected, while heel-striking athletes saw the largest loading changes.

The clinical context matters. Tibial and metatarsal bone-stress injuries have been the most common training-loss diagnosis among elite distance runners since the mid-2020s, and several team doctors have publicly speculated about a super-shoe contribution without controlled data to back the claim. The Mass General Brigham work is not a smoking gun -- it is a single, small-sample study without prospective injury follow-up -- but it is the cleanest measurement yet of the mechanism that those doctors have suspected. Crucially, the researchers found that the loading differences were not present in the lightweight racing-flat trials, suggesting it is the carbon plate and very tall foam stack, rather than light weight alone, that drives the effect.

The authors' practical recommendation is conservative and unsurprising: rotate shoe categories across the training week, restrict carbon-plated wear to race-pace sessions and races themselves, and adapt to the geometry gradually rather than swapping into a brand-new model in race week. None of that will shock a competitive coach, but it gives clinical weight to a practice that has, until now, been mostly oral tradition. The paper also urges shoe brands to make geometry and stiffness specs explicit in their marketing rather than relying on athlete testimonials, so coaches and physiotherapists can pattern-match across shoes and across runners more usefully.

For Running Lookout readers tracking the super-shoe arms race, the study sits next to a separate, larger Danish data set that has questioned long-standing assumptions about how running injuries actually develop, and a UK parkrun analysis showing 4.8 per cent of adult finishers now wear carbon-plated racers on weekend mornings. The combined picture is that super shoes are no longer the preserve of elites, that their performance benefits are well documented and that the injury cost, while small in any single run, is starting to look real over a season. Expect more controlled studies in the back half of 2026, and a tighter conversation between brands, athletics governing bodies and team doctors on how to phase the next generation of shoes into elite training.